Tris Pharma chooses software to meet serialisation regulations

The pharmaceuticals manufacturer chose software from Adents for upcoming compliance regulations

US specialty pharmaceutical company, Tris Pharma, has chosen Adents, a provider of serialisation and Track and Trace software solutions, for regulation-compliant serialisation.

Tris Pharma specialises in research, development and manufacturing of both OTC / Rx branded and generic products.

The choice of software is to assure compliance with upcoming US serialisation deadlines; by November 2017, pharmaceutical manufacturers are required to print a unique product identification code on all Rx units of sale and homogenous cases distributed domestically.

The Adents serialisation and aggregation suite of software enables companies to achieve traceability and documentation compliance easily, addressing both current and emerging regulations while also minimising impact on production processes and productivity.

Adents standardised software is designed to be flexible, scalable and quick to deploy. Its configuration takes place completely at site level, making per-line configuration unnecessary. It also helps eliminate counterfeiting.

The software is hardware agnostic, meaning it is compatible with a wide range of equipment.

Currently, Tris handles work order entry manually but is looking to migrate to JD Edwards-generated work orders.

With the Adents Supervisor platform, whose function is to manage and distribute serialised codes, the exchange of serialisation data will be significantly easier.

Companies